Ian Krop Selected Research

Ian Krop Research Topics

Disease

45	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2002
26	Neoplasms (Cancer) 03/2024 - 05/2003
8	Brain Neoplasms (Brain Tumor) 12/2023 - 07/2014
5	Nausea 01/2023 - 07/2012
5	Fatigue 01/2023 - 07/2012
4	Triple Negative Breast Neoplasms 03/2024 - 08/2017
4	Vomiting 01/2023 - 07/2012
4	Thrombocytopenia (Thrombopenia) 04/2020 - 01/2014
4	Diarrhea 01/2020 - 07/2012
3	Disease Progression 01/2023 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2017
2	Pathologic Complete Response 01/2023 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2014
2	Meningeal Carcinomatosis 08/2020 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 10/2019
1	Alopecia (Baldness) 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Left Ventricular Dysfunction 02/2022
1	Cardiotoxicity 02/2022
1	Residual Neoplasm 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Headache (Headaches) 01/2018
1	Constipation 01/2018
1	Epistaxis (Nosebleed) 01/2018
1	Breast Cancer 3 01/2017
1	Neutropenia 01/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2015
1	Exanthema (Rash) 01/2015
1	Heart Failure 07/2014

Drug/Important Bio-Agent (IBA)

18	Trastuzumab (Herceptin)FDA Link 01/2023 - 02/2009
11	Ado-Trastuzumab EmtansineIBA 05/2024 - 01/2014
7	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 01/2015
7	human ERBB2 proteinIBA 01/2021 - 07/2014
6	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 01/2014
6	Hormones (Hormone)IBA 03/2024 - 08/2017
6	pembrolizumabIBA 12/2023 - 01/2020
6	Estrogen ReceptorsIBA 01/2023 - 01/2002
5	trastuzumab deruxtecanIBA 05/2024 - 01/2020
5	pertuzumabIBA 01/2022 - 10/2013
4	tucatinibIBA 01/2023 - 01/2018
4	taxaneIBA 04/2020 - 12/2009
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2010
3	Capecitabine (Xeloda)FDA Link 01/2023 - 01/2014
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2014
3	Transaminases (Aminotransferases)IBA 04/2020 - 01/2014
3	Lapatinib (GW572016)FDA Link 01/2020 - 01/2013
3	Docetaxel (Taxotere)FDA Link 01/2014 - 03/2013
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2005
2	Fulvestrant (Faslodex)FDA Link 01/2023 - 01/2016
2	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2023 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2023
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2002
2	Immune Checkpoint InhibitorsIBA 01/2021 - 08/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 12/2005
2	3- (4- ((4- chlorophenyl)sulfonyl)- 4- (2,5- difluorophenyl)cyclohexyl)propanoic acidIBA 03/2013 - 07/2012
1	Surface Antigens (Surface Antigen)IBA 03/2024
1	Monoclonal AntibodiesIBA 03/2024
1	Topoisomerase I InhibitorsIBA 03/2024
1	Cytotoxins (Cytolysins)IBA 03/2024
1	Epidermal Growth Factor (EGF)IBA 03/2024
1	DHES0815AIBA 01/2024
1	AntibodiesIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Therapeutic UsesIBA 01/2021
1	CytokinesIBA 01/2021
1	ChromatinIBA 01/2021
1	eribulin FDA Link 01/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 12/2020
1	exemestane (Aromasin)FDA Link 12/2020
1	enzalutamideIBA 12/2020
1	Letrozole (Femara)FDA LinkGeneric 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	CalicheamicinsIBA 10/2019
1	PF-06647263IBA 10/2019
1	APTIBA 07/2019
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	gancotamabIBA 08/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017
1	Capsules (Microcapsules)IBA 01/2017
1	Growth InhibitorsIBA 01/2017
1	Aromatase InhibitorsIBA 01/2016
1	MK 2206IBA 03/2015
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2015
1	XL147IBA 01/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2014

Therapy/Procedure

22	Therapeutics 03/2024 - 01/2012
6	Drug Therapy (Chemotherapy) 01/2022 - 03/2013
2	Aftercare (After-Treatment) 12/2023 - 01/2018
1	Neoadjuvant Therapy 02/2022
1	Immunotherapy 08/2019
1	Investigational Therapies (Experimental Therapy) 03/2013